Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | AMGN | BMY | VRTX | REGN |
| Company | Orphazyme A/S ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.9060 | 265.72 | 44.68 | 393.52 | 881.72 |
| High | 0.9571 | 271.68 | 45.37 | 399.68 | 887.48 |
| Low | 0.8457 | 265.72 | 44.34 | 393.49 | 875.22 |
| Last | 0.8700 | 269.98 | 44.85 | 397.48 | 883.20 |
| Change | -0.0200 | +0.60 | +0.15 | -0.22 | -7.48 |
| % Change | -2.25% | +0.22% | +0.34% | -0.06% | -0.84% |
| Volume | 941,400 | 2,436,900 | 21,281,900 | 682,400 | 505,600 |
| 20-Day Average Volume | 1,980,090 | 2,156,940 | 13,205,370 | 943,625 | 457,100 |
| Previous Close | 0.8900 | 269.38 | 44.70 | 397.70 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 269.99 | 49.47 | 401.28 | 918.54 |
| 20-Day Raw Stochastic | 41.76% | 40.03% | 5.16% | 21.25% | 8.40% |
| 20-Day Relative Strength | 36.52% | 45.47% | 29.15% | 42.53% | 33.09% |
| Weighted Alpha | -87.89 | +9.45 | -34.43 | +14.78 | +9.82 |
| Today's Opinion | 100% Sell | 72% Sell | 88% Sell | 8% Buy | 8% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 88% Sell | 8% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 8% Buy | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +0.39% since 04/19/24 | -8.34% since 04/19/24 | +0.81% since 04/19/24 | -1.52% since 04/19/24 |
| Low | 0.8275 on 03/29/22 | 265.72 on 04/26/24 | 44.34 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 |
| High | 0.9600 on 03/29/22 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -4.18% since 03/26/24 | -14.65% since 03/26/24 | -5.01% since 03/26/24 | -8.34% since 03/26/24 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 1.3720 on 03/10/22 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -13.40% since 01/26/24 | -9.76% since 01/26/24 | -7.60% since 01/26/24 | -6.05% since 01/26/24 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 2.7500 on 01/03/22 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | +0.10% since 10/26/23 | -15.33% since 10/26/23 | +10.02% since 10/26/23 | +11.51% since 10/26/23 |
| Low | 0.5101 on 03/14/22 | 249.70 on 10/31/23 | 44.34 on 04/26/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 5.4900 on 10/13/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 144,810,784 | 90,900,144 | 102,732,288 | 96,941,800 |
| Shares Outstanding, K | 35,312 | 536,376 | 2,026,759 | 258,459 | 109,762 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -97,010,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 11,477,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 1,762,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 1.68 | 0.58 | 0.39 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | -4.40 on 04/25/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 04/05/22 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 6.08 | 29.59 | 23.70 |